194 related articles for article (PubMed ID: 24651368)
1. Expression of dual-specificity phosphatase 5 pseudogene 1 (DUSP5P1) in tumor cells.
Staege MS; Müller K; Kewitz S; Volkmer I; Mauz-Körholz C; Bernig T; Körholz D
PLoS One; 2014; 9(2):e89577. PubMed ID: 24651368
[TBL] [Abstract][Full Text] [Related]
2. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
[TBL] [Abstract][Full Text] [Related]
3. High expression of dual-specificity phosphatase 5 pseudogene 1 (DUSP5P1) is associated with poor prognosis in acute myeloid leukemia.
Zhou LY; Yin JY; Tang Q; Zhai LL; Zhang TJ; Wang YX; Yang DQ; Qian J; Lin J; Deng ZQ
Int J Clin Exp Pathol; 2015; 8(12):16073-80. PubMed ID: 26884884
[TBL] [Abstract][Full Text] [Related]
4. C8orf76 Promotes Gastric Tumorigenicity and Metastasis by Directly Inducing lncRNA DUSP5P1 and Associates with Patient Outcomes.
Wang X; Liang Q; Zhang L; Gou H; Li Z; Chen H; Dong Y; Ji J; Yu J
Clin Cancer Res; 2019 May; 25(10):3128-3140. PubMed ID: 30733230
[TBL] [Abstract][Full Text] [Related]
5. PU.1 is a potent tumor suppressor in classical Hodgkin lymphoma cells.
Yuki H; Ueno S; Tatetsu H; Niiro H; Iino T; Endo S; Kawano Y; Komohara Y; Takeya M; Hata H; Okada S; Watanabe T; Akashi K; Mitsuya H; Okuno Y
Blood; 2013 Feb; 121(6):962-70. PubMed ID: 23212521
[TBL] [Abstract][Full Text] [Related]
6. Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma.
Tiacci E; Döring C; Brune V; van Noesel CJ; Klapper W; Mechtersheimer G; Falini B; Küppers R; Hansmann ML
Blood; 2012 Nov; 120(23):4609-20. PubMed ID: 22955914
[TBL] [Abstract][Full Text] [Related]
7. Dual Specificity Phosphatase 5 Is Essential for T Cell Survival.
Kutty RG; Xin G; Schauder DM; Cossette SM; Bordas M; Cui W; Ramchandran R
PLoS One; 2016; 11(12):e0167246. PubMed ID: 27936095
[TBL] [Abstract][Full Text] [Related]
8. Identification of a candidate alternative promoter region of the human Bcl2L11 (Bim) gene.
Gaviraghi M; Caricasole A; Costanzo C; Diamanti D; Dandrea M; Donadelli M; Scarpa A; Palmieri M
BMC Mol Biol; 2008 Jun; 9():56. PubMed ID: 18549468
[TBL] [Abstract][Full Text] [Related]
9. Hodgkin cells accumulate mRNA for bcl-2.
Hell K; Lorenzen J; Fischer R; Hansmann ML
Lab Invest; 1995 Oct; 73(4):492-6. PubMed ID: 7474920
[TBL] [Abstract][Full Text] [Related]
10. Glutathione-S-transferases and Chemotherapy Resistance of Hodgkin's Lymphoma Cell Lines.
Bernig T; Ritz S; Brodt G; Volkmer I; Staege MS
Anticancer Res; 2016 Aug; 36(8):3905-15. PubMed ID: 27466493
[TBL] [Abstract][Full Text] [Related]
11. Expression of bcl-2 protein and transcription of the Epstein-Barr virus bcl-2 homologue BHRF-1 in Hodgkin's disease: implications for different pathogenic mechanisms.
Jiwa NM; Oudejans JJ; Bai MC; Van den Brule AJ; Horstman A; Vos W; Van der Valk P; Kluin PM; Walboomers JM; Meijer CJ
Histopathology; 1995 Jun; 26(6):547-53. PubMed ID: 7665145
[TBL] [Abstract][Full Text] [Related]
12. Epstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim.
Paschos K; Smith P; Anderton E; Middeldorp JM; White RE; Allday MJ
PLoS Pathog; 2009 Jun; 5(6):e1000492. PubMed ID: 19557159
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of homeobox genes in Hodgkin lymphoma cell lines identifies dysregulated expression of HOXB9 mediated via ERK5 signaling and BMI1.
Nagel S; Burek C; Venturini L; Scherr M; Quentmeier H; Meyer C; Rosenwald A; Drexler HG; MacLeod RA
Blood; 2007 Apr; 109(7):3015-23. PubMed ID: 17148583
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus and bcl-2 protein overexpression are not detected in the neoplastic cells of nodular lymphocyte predominance Hodgkin's disease.
Alkan S; Ross CW; Hanson CA; Schnitzer B
Mod Pathol; 1995 Jun; 8(5):544-7. PubMed ID: 7675775
[TBL] [Abstract][Full Text] [Related]
15. Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile.
Gibcus JH; Tan LP; Harms G; Schakel RN; de Jong D; Blokzijl T; Möller P; Poppema S; Kroesen BJ; van den Berg A
Neoplasia; 2009 Feb; 11(2):167-76. PubMed ID: 19177201
[TBL] [Abstract][Full Text] [Related]
16. Opposing regulation of BIM and BCL2 controls glucocorticoid-induced apoptosis of pediatric acute lymphoblastic leukemia cells.
Jing D; Bhadri VA; Beck D; Thoms JA; Yakob NA; Wong JW; Knezevic K; Pimanda JE; Lock RB
Blood; 2015 Jan; 125(2):273-83. PubMed ID: 25336632
[TBL] [Abstract][Full Text] [Related]
17. KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma.
Guan H; Xie L; Leithäuser F; Flossbach L; Möller P; Wirth T; Ushmorov A
Blood; 2010 Sep; 116(9):1469-78. PubMed ID: 20519630
[TBL] [Abstract][Full Text] [Related]
18. Etodolac inhibits EBER expression and induces Bcl-2-regulated apoptosis in Burkitt's lymphoma cells.
Kobayashi M; Nakamura S; Shibata K; Sahara N; Shigeno K; Shinjo K; Naito K; Ohnishi K
Eur J Haematol; 2005 Sep; 75(3):212-20. PubMed ID: 16104877
[TBL] [Abstract][Full Text] [Related]
19. DUSP5 and DUSP6, two ERK specific phosphatases, are markers of a higher MAPK signaling activation in BRAF mutated thyroid cancers.
Buffet C; Hecale-Perlemoine K; Bricaire L; Dumont F; Baudry C; Tissier F; Bertherat J; Cochand-Priollet B; Raffin-Sanson ML; Cormier F; Groussin L
PLoS One; 2017; 12(9):e0184861. PubMed ID: 28910386
[TBL] [Abstract][Full Text] [Related]
20. TGFbeta-mediated apoptosis of Burkitt's lymphoma BL41 cells is associated with the relocation of mitochondrial BimEL.
Clybouw C; Mchichi BE; Hadji A; Portier A; Auffredou MT; Arnoult D; Leca G; Vazquez A
Oncogene; 2008 May; 27(24):3446-56. PubMed ID: 18193085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
